185 related articles for article (PubMed ID: 37672168)
1. Advantage of ostarine over raloxifene and their combined treatments for muscle of estrogen-deficient rats.
Roch PJ; Noisser L; Böker KO; Hoffmann DB; Schilling AF; Sehmisch S; Komrakova M
J Endocrinol Invest; 2024 Mar; 47(3):709-720. PubMed ID: 37672168
[TBL] [Abstract][Full Text] [Related]
2. Combination of selective androgen and estrogen receptor modulators in orchiectomized rats.
Roch PJ; Wolgast V; Gebhardt MM; Böker KO; Hoffmann DB; Saul D; Schilling AF; Sehmisch S; Komrakova M
J Endocrinol Invest; 2022 Aug; 45(8):1555-1568. PubMed ID: 35429299
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis.
Hoffmann DB; Komrakova M; Pflug S; von Oertzen M; Saul D; Weiser L; Walde TA; Wassmann M; Schilling AF; Lehmann W; Sehmisch S
J Bone Miner Metab; 2019 Mar; 37(2):243-255. PubMed ID: 29785666
[TBL] [Abstract][Full Text] [Related]
4. Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model.
Roch PJ; Henkies D; Carstens JC; Krischek C; Lehmann W; Komrakova M; Sehmisch S
Front Endocrinol (Lausanne); 2020; 11():556581. PubMed ID: 33042018
[TBL] [Abstract][Full Text] [Related]
5. Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.
Stygar D; Muravitskaya N; Eriksson B; Eriksson H; Sahlin L
Reprod Biol Endocrinol; 2003 May; 1():40. PubMed ID: 12777179
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells.
Shen HH; Yang CY; Kung CW; Chen SY; Wu HM; Cheng PY; Lam KK; Lee YM
J Biomed Sci; 2019 Aug; 26(1):62. PubMed ID: 31470850
[TBL] [Abstract][Full Text] [Related]
7. The Selective Androgen Receptor Modulator Ostarine Improves Bone Healing in Ovariectomized Rats.
Komrakova M; Furtwängler J; Hoffmann DB; Lehmann W; Schilling AF; Sehmisch S
Calcif Tissue Int; 2020 Feb; 106(2):147-157. PubMed ID: 31531719
[TBL] [Abstract][Full Text] [Related]
8. Expressions of vascular endothelial growth factor and nitric oxide synthase III in the thyroid gland of ovariectomized rats are upregulated by estrogen and selective estrogen receptor modulators.
de Araujo LF; Grozovsky R; dos Santos Pereira MJ; de Carvalho JJ; Vaisman M; Carvalho DP
Thyroid; 2010 Jan; 20(1):85-92. PubMed ID: 20017619
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Jee WS; Sato M
J Bone Miner Metab; 2005; 23 Suppl():62-8. PubMed ID: 15984416
[TBL] [Abstract][Full Text] [Related]
10. A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats.
Komrakova M; Büchler G; Böker KO; Lehmann W; Schilling AF; Roch PJ; Taudien S; Hoffmann DB; Sehmisch S
J Endocrinol Invest; 2022 Dec; 45(12):2299-2311. PubMed ID: 35867330
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
Gogos A; van den Buuse M
Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
[TBL] [Abstract][Full Text] [Related]
12. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene retards cartilage degradation and improves subchondral bone micro-architecture in ovariectomized rats with patella baja-induced - patellofemoral joint osteoarthritis.
Bei MJ; Tian FM; Xiao YP; Cao XH; Liu N; Zheng ZY; Dai MW; Wang WY; Song HP; Zhang L
Osteoarthritis Cartilage; 2020 Mar; 28(3):344-355. PubMed ID: 31326553
[TBL] [Abstract][Full Text] [Related]
14. The selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats.
Lamas AZ; Nascimento AM; Medeiros ARS; Caliman IF; Dalpiaz PLM; Firmes LB; Sousa GJ; Oliveira PWC; Andrade TU; Reis AM; Gouvea SA; Bissoli NS
Pharmacol Rep; 2017 Aug; 69(4):798-805. PubMed ID: 28591668
[TBL] [Abstract][Full Text] [Related]
15. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of long-term treatment with raloxifene, a selective estrogen receptor modulator, on myocardial ischemia/reperfusion injury in ovariectomized rats.
Chung MT; Cheng PY; Lam KK; Chen SY; Ting YF; Yen MH; Lee YM
Menopause; 2010; 17(1):127-34. PubMed ID: 19745773
[TBL] [Abstract][Full Text] [Related]
17. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS
J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteogenic markers after administration of selective estrogen receptor modulators during implant placement in the osteoporotic rat maxilla.
Park S; Heo HA; Kim KW; Pyo SW
J Oral Sci; 2022 Jan; 64(1):53-58. PubMed ID: 34955485
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats.
Meli R; Pacilio M; Raso GM; Esposito E; Coppola A; Nasti A; Di Carlo C; Nappi C; Di Carlo R
Endocrinology; 2004 Jul; 145(7):3115-21. PubMed ID: 15059958
[TBL] [Abstract][Full Text] [Related]
20. Effects of estradiol benzoate, raloxifen and an ethanolic extract of Cimicifuga racemosa in nonclassical estrogen regulated organs of ovariectomized rats.
Seidlova-Wuttke D; Jarry H; Wuttke W
Planta Med; 2009 Oct; 75(12):1279-85. PubMed ID: 19350480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
